Global Passive Immunizing Drugs against Rabies Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.
The global Passive Immunizing Drugs against Rabies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Passive Immunizing Drugs against Rabies Industry Forecast” looks at past sales and reviews total world Passive Immunizing Drugs against Rabies sales in 2023, providing a comprehensive analysis by region and market sector of projected Passive Immunizing Drugs against Rabies sales for 2024 through 2030. With Passive Immunizing Drugs against Rabies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Immunizing Drugs against Rabies industry.
This Insight Report provides a comprehensive analysis of the global Passive Immunizing Drugs against Rabies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Immunizing Drugs against Rabies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Passive Immunizing Drugs against Rabies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Immunizing Drugs against Rabies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Immunizing Drugs against Rabies.
United States market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Passive Immunizing Drugs against Rabies players cover Kedrion Biopharma, Grifols, Sanofi Pasteur, Kamada, Zydus Lifesciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Immunizing Drugs against Rabies market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Passive Immunizing Drugs against Rabies market?
What factors are driving Passive Immunizing Drugs against Rabies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Passive Immunizing Drugs against Rabies market opportunities vary by end market size?
How does Passive Immunizing Drugs against Rabies break out by Type, by Application?
Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.
The global Passive Immunizing Drugs against Rabies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Passive Immunizing Drugs against Rabies Industry Forecast” looks at past sales and reviews total world Passive Immunizing Drugs against Rabies sales in 2023, providing a comprehensive analysis by region and market sector of projected Passive Immunizing Drugs against Rabies sales for 2024 through 2030. With Passive Immunizing Drugs against Rabies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Immunizing Drugs against Rabies industry.
This Insight Report provides a comprehensive analysis of the global Passive Immunizing Drugs against Rabies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Immunizing Drugs against Rabies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Passive Immunizing Drugs against Rabies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Immunizing Drugs against Rabies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Immunizing Drugs against Rabies.
United States market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Passive Immunizing Drugs against Rabies players cover Kedrion Biopharma, Grifols, Sanofi Pasteur, Kamada, Zydus Lifesciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Immunizing Drugs against Rabies market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Rabies Immunoglobulin
- Anti-rabies Serum
- Rabies Virus Monoclonal Antibody
- Category II Exposure
- Category III Exposure
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Kedrion Biopharma
- Grifols
- Sanofi Pasteur
- Kamada
- Zydus Lifesciences
- Serum Institute of India
- Sichuan Yuanda Shuyang Pharmaceutical
- Sinopharm Group
- Haffkine Bio-Pharmaceutical
- Bharat Biotech
- Sharon Bio-Medicine
- Wuhan Institute of Biological Products
- North China Pharmaceutical
- Xingmeng Biopharmaceuticals (Suzhou)
- Hualan Biological Engineering
- Shanxi Kangbao Biological Product
What is the 10-year outlook for the global Passive Immunizing Drugs against Rabies market?
What factors are driving Passive Immunizing Drugs against Rabies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Passive Immunizing Drugs against Rabies market opportunities vary by end market size?
How does Passive Immunizing Drugs against Rabies break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Immunizing Drugs against Rabies Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Passive Immunizing Drugs against Rabies by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Passive Immunizing Drugs against Rabies by Country/Region, 2019, 2023 & 2030
2.2 Passive Immunizing Drugs against Rabies Segment by Type
2.2.1 Rabies Immunoglobulin
2.2.2 Anti-rabies Serum
2.2.3 Rabies Virus Monoclonal Antibody
2.3 Passive Immunizing Drugs against Rabies Sales by Type
2.3.1 Global Passive Immunizing Drugs against Rabies Sales Market Share by Type (2019-2024)
2.3.2 Global Passive Immunizing Drugs against Rabies Revenue and Market Share by Type (2019-2024)
2.3.3 Global Passive Immunizing Drugs against Rabies Sale Price by Type (2019-2024)
2.4 Passive Immunizing Drugs against Rabies Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Passive Immunizing Drugs against Rabies Sales by Application
2.5.1 Global Passive Immunizing Drugs against Rabies Sale Market Share by Application (2019-2024)
2.5.2 Global Passive Immunizing Drugs against Rabies Revenue and Market Share by Application (2019-2024)
2.5.3 Global Passive Immunizing Drugs against Rabies Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Passive Immunizing Drugs against Rabies Breakdown Data by Company
3.1.1 Global Passive Immunizing Drugs against Rabies Annual Sales by Company (2019-2024)
3.1.2 Global Passive Immunizing Drugs against Rabies Sales Market Share by Company (2019-2024)
3.2 Global Passive Immunizing Drugs against Rabies Annual Revenue by Company (2019-2024)
3.2.1 Global Passive Immunizing Drugs against Rabies Revenue by Company (2019-2024)
3.2.2 Global Passive Immunizing Drugs against Rabies Revenue Market Share by Company (2019-2024)
3.3 Global Passive Immunizing Drugs against Rabies Sale Price by Company
3.4 Key Manufacturers Passive Immunizing Drugs against Rabies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Immunizing Drugs against Rabies Product Location Distribution
3.4.2 Players Passive Immunizing Drugs against Rabies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PASSIVE IMMUNIZING DRUGS AGAINST RABIES BY GEOGRAPHIC REGION
4.1 World Historic Passive Immunizing Drugs against Rabies Market Size by Geographic Region (2019-2024)
4.1.1 Global Passive Immunizing Drugs against Rabies Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Passive Immunizing Drugs against Rabies Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Passive Immunizing Drugs against Rabies Market Size by Country/Region (2019-2024)
4.2.1 Global Passive Immunizing Drugs against Rabies Annual Sales by Country/Region (2019-2024)
4.2.2 Global Passive Immunizing Drugs against Rabies Annual Revenue by Country/Region (2019-2024)
4.3 Americas Passive Immunizing Drugs against Rabies Sales Growth
4.4 APAC Passive Immunizing Drugs against Rabies Sales Growth
4.5 Europe Passive Immunizing Drugs against Rabies Sales Growth
4.6 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Growth
5 AMERICAS
5.1 Americas Passive Immunizing Drugs against Rabies Sales by Country
5.1.1 Americas Passive Immunizing Drugs against Rabies Sales by Country (2019-2024)
5.1.2 Americas Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024)
5.2 Americas Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
5.3 Americas Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Immunizing Drugs against Rabies Sales by Region
6.1.1 APAC Passive Immunizing Drugs against Rabies Sales by Region (2019-2024)
6.1.2 APAC Passive Immunizing Drugs against Rabies Revenue by Region (2019-2024)
6.2 APAC Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
6.3 APAC Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Immunizing Drugs against Rabies by Country
7.1.1 Europe Passive Immunizing Drugs against Rabies Sales by Country (2019-2024)
7.1.2 Europe Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024)
7.2 Europe Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
7.3 Europe Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Immunizing Drugs against Rabies by Country
8.1.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Country (2019-2024)
8.1.2 Middle East & Africa Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024)
8.2 Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
8.3 Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Immunizing Drugs against Rabies
10.3 Manufacturing Process Analysis of Passive Immunizing Drugs against Rabies
10.4 Industry Chain Structure of Passive Immunizing Drugs against Rabies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Immunizing Drugs against Rabies Distributors
11.3 Passive Immunizing Drugs against Rabies Customer
12 WORLD FORECAST REVIEW FOR PASSIVE IMMUNIZING DRUGS AGAINST RABIES BY GEOGRAPHIC REGION
12.1 Global Passive Immunizing Drugs against Rabies Market Size Forecast by Region
12.1.1 Global Passive Immunizing Drugs against Rabies Forecast by Region (2025-2030)
12.1.2 Global Passive Immunizing Drugs against Rabies Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Passive Immunizing Drugs against Rabies Forecast by Type (2025-2030)
12.7 Global Passive Immunizing Drugs against Rabies Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Kedrion Biopharma
13.1.1 Kedrion Biopharma Company Information
13.1.2 Kedrion Biopharma Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.1.3 Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Kedrion Biopharma Main Business Overview
13.1.5 Kedrion Biopharma Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.2.3 Grifols Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Kamada
13.4.1 Kamada Company Information
13.4.2 Kamada Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.4.3 Kamada Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Kamada Main Business Overview
13.4.5 Kamada Latest Developments
13.5 Zydus Lifesciences
13.5.1 Zydus Lifesciences Company Information
13.5.2 Zydus Lifesciences Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.5.3 Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zydus Lifesciences Main Business Overview
13.5.5 Zydus Lifesciences Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.6.3 Serum Institute of India Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 Sichuan Yuanda Shuyang Pharmaceutical
13.7.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
13.7.2 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.7.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sichuan Yuanda Shuyang Pharmaceutical Main Business Overview
13.7.5 Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
13.8 Sinopharm Group
13.8.1 Sinopharm Group Company Information
13.8.2 Sinopharm Group Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.8.3 Sinopharm Group Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sinopharm Group Main Business Overview
13.8.5 Sinopharm Group Latest Developments
13.9 Haffkine Bio-Pharmaceutical
13.9.1 Haffkine Bio-Pharmaceutical Company Information
13.9.2 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.9.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Haffkine Bio-Pharmaceutical Main Business Overview
13.9.5 Haffkine Bio-Pharmaceutical Latest Developments
13.10 Bharat Biotech
13.10.1 Bharat Biotech Company Information
13.10.2 Bharat Biotech Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.10.3 Bharat Biotech Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bharat Biotech Main Business Overview
13.10.5 Bharat Biotech Latest Developments
13.11 Sharon Bio-Medicine
13.11.1 Sharon Bio-Medicine Company Information
13.11.2 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.11.3 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sharon Bio-Medicine Main Business Overview
13.11.5 Sharon Bio-Medicine Latest Developments
13.12 Wuhan Institute of Biological Products
13.12.1 Wuhan Institute of Biological Products Company Information
13.12.2 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.12.3 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Wuhan Institute of Biological Products Main Business Overview
13.12.5 Wuhan Institute of Biological Products Latest Developments
13.13 North China Pharmaceutical
13.13.1 North China Pharmaceutical Company Information
13.13.2 North China Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.13.3 North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 North China Pharmaceutical Main Business Overview
13.13.5 North China Pharmaceutical Latest Developments
13.14 Xingmeng Biopharmaceuticals (Suzhou)
13.14.1 Xingmeng Biopharmaceuticals (Suzhou) Company Information
13.14.2 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.14.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Xingmeng Biopharmaceuticals (Suzhou) Main Business Overview
13.14.5 Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
13.15 Hualan Biological Engineering
13.15.1 Hualan Biological Engineering Company Information
13.15.2 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.15.3 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Hualan Biological Engineering Main Business Overview
13.15.5 Hualan Biological Engineering Latest Developments
13.16 Shanxi Kangbao Biological Product
13.16.1 Shanxi Kangbao Biological Product Company Information
13.16.2 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.16.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shanxi Kangbao Biological Product Main Business Overview
13.16.5 Shanxi Kangbao Biological Product Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Passive Immunizing Drugs against Rabies Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Passive Immunizing Drugs against Rabies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Rabies Immunoglobulin
Table 4. Major Players of Anti-rabies Serum
Table 5. Major Players of Rabies Virus Monoclonal Antibody
Table 6. Global Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 7. Global Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Table 8. Global Passive Immunizing Drugs against Rabies Revenue byType (2019-2024) & ($ million)
Table 9. Global Passive Immunizing Drugs against Rabies Revenue Market Share byType (2019-2024)
Table 10. Global Passive Immunizing Drugs against Rabies Sale Price byType (2019-2024) & (US$/Dose)
Table 11. Global Passive Immunizing Drugs against Rabies Sale by Application (2019-2024) & (K Dose)
Table 12. Global Passive Immunizing Drugs against Rabies Sale Market Share by Application (2019-2024)
Table 13. Global Passive Immunizing Drugs against Rabies Revenue by Application (2019-2024) & ($ million)
Table 14. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application (2019-2024)
Table 15. Global Passive Immunizing Drugs against Rabies Sale Price by Application (2019-2024) & (US$/Dose)
Table 16. Global Passive Immunizing Drugs against Rabies Sales by Company (2019-2024) & (K Dose)
Table 17. Global Passive Immunizing Drugs against Rabies Sales Market Share by Company (2019-2024)
Table 18. Global Passive Immunizing Drugs against Rabies Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Company (2019-2024)
Table 20. Global Passive Immunizing Drugs against Rabies Sale Price by Company (2019-2024) & (US$/Dose)
Table 21. Key Manufacturers Passive Immunizing Drugs against Rabies Producing Area Distribution and Sales Area
Table 22. Players Passive Immunizing Drugs against Rabies Products Offered
Table 23. Passive Immunizing Drugs against Rabies Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Passive Immunizing Drugs against Rabies Sales by Geographic Region (2019-2024) & (K Dose)
Table 27. Global Passive Immunizing Drugs against Rabies Sales Market Share Geographic Region (2019-2024)
Table 28. Global Passive Immunizing Drugs against Rabies Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Passive Immunizing Drugs against Rabies Sales by Country/Region (2019-2024) & (K Dose)
Table 31. Global Passive Immunizing Drugs against Rabies Sales Market Share by Country/Region (2019-2024)
Table 32. Global Passive Immunizing Drugs against Rabies Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Passive Immunizing Drugs against Rabies Sales by Country (2019-2024) & (K Dose)
Table 35. Americas Passive Immunizing Drugs against Rabies Sales Market Share by Country (2019-2024)
Table 36. Americas Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 38. Americas Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 39. APAC Passive Immunizing Drugs against Rabies Sales by Region (2019-2024) & (K Dose)
Table 40. APAC Passive Immunizing Drugs against Rabies Sales Market Share by Region (2019-2024)
Table 41. APAC Passive Immunizing Drugs against Rabies Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 43. APAC Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 44. Europe Passive Immunizing Drugs against Rabies Sales by Country (2019-2024) & (K Dose)
Table 45. Europe Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 47. Europe Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 48. Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Country (2019-2024) & (K Dose)
Table 49. Middle East & Africa Passive Immunizing Drugs against Rabies Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 51. Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Passive Immunizing Drugs against Rabies
Table 53. Key Market Challenges & Risks of Passive Immunizing Drugs against Rabies
Table 54. Key IndustryTrends of Passive Immunizing Drugs against Rabies
Table 55. Passive Immunizing Drugs against Rabies Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Passive Immunizing Drugs against Rabies Distributors List
Table 58. Passive Immunizing Drugs against Rabies Customer List
Table 59. Global Passive Immunizing Drugs against Rabies SalesForecast by Region (2025-2030) & (K Dose)
Table 60. Global Passive Immunizing Drugs against Rabies RevenueForecast by Region (2025-2030) & ($ millions)
Table 61. Americas Passive Immunizing Drugs against Rabies SalesForecast by Country (2025-2030) & (K Dose)
Table 62. Americas Passive Immunizing Drugs against Rabies Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 63. APAC Passive Immunizing Drugs against Rabies SalesForecast by Region (2025-2030) & (K Dose)
Table 64. APAC Passive Immunizing Drugs against Rabies Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Europe Passive Immunizing Drugs against Rabies SalesForecast by Country (2025-2030) & (K Dose)
Table 66. Europe Passive Immunizing Drugs against Rabies RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Passive Immunizing Drugs against Rabies SalesForecast by Country (2025-2030) & (K Dose)
Table 68. Middle East & Africa Passive Immunizing Drugs against Rabies RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Global Passive Immunizing Drugs against Rabies SalesForecast byType (2025-2030) & (K Dose)
Table 70. Global Passive Immunizing Drugs against Rabies RevenueForecast byType (2025-2030) & ($ millions)
Table 71. Global Passive Immunizing Drugs against Rabies SalesForecast by Application (2025-2030) & (K Dose)
Table 72. Global Passive Immunizing Drugs against Rabies RevenueForecast by Application (2025-2030) & ($ millions)
Table 73. Kedrion Biopharma Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 74. Kedrion Biopharma Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 75. Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 76. Kedrion Biopharma Main Business
Table 77. Kedrion Biopharma Latest Developments
Table 78. Grifols Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 79. Grifols Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 80. Grifols Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 81. Grifols Main Business
Table 82. Grifols Latest Developments
Table 83. Sanofi Pasteur Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 85. Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Kamada Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 89. Kamada Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 90. Kamada Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 91. Kamada Main Business
Table 92. Kamada Latest Developments
Table 93. Zydus Lifesciences Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 94. Zydus Lifesciences Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 95. Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 96. Zydus Lifesciences Main Business
Table 97. Zydus Lifesciences Latest Developments
Table 98. Serum Institute of India Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 100. Serum Institute of India Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments
Table 103. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 104. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 105. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 106. Sichuan Yuanda Shuyang Pharmaceutical Main Business
Table 107. Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
Table 108. Sinopharm Group Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 109. Sinopharm Group Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 110. Sinopharm Group Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 111. Sinopharm Group Main Business
Table 112. Sinopharm Group Latest Developments
Table 113. Haffkine Bio-Pharmaceutical Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 114. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 115. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 116. Haffkine Bio-Pharmaceutical Main Business
Table 117. Haffkine Bio-Pharmaceutical Latest Developments
Table 118. Bharat Biotech Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 119. Bharat Biotech Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 120. Bharat Biotech Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 121. Bharat Biotech Main Business
Table 122. Bharat Biotech Latest Developments
Table 123. Sharon Bio-Medicine Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 124. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 125. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 126. Sharon Bio-Medicine Main Business
Table 127. Sharon Bio-Medicine Latest Developments
Table 128. Wuhan Institute of Biological Products Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 130. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 131. Wuhan Institute of Biological Products Main Business
Table 132. Wuhan Institute of Biological Products Latest Developments
Table 133. North China Pharmaceutical Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 134. North China Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 135. North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 136. North China Pharmaceutical Main Business
Table 137. North China Pharmaceutical Latest Developments
Table 138. Xingmeng Biopharmaceuticals (Suzhou) Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 139. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 140. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 141. Xingmeng Biopharmaceuticals (Suzhou) Main Business
Table 142. Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
Table 143. Hualan Biological Engineering Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 144. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 145. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 146. Hualan Biological Engineering Main Business
Table 147. Hualan Biological Engineering Latest Developments
Table 148. Shanxi Kangbao Biological Product Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 150. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 151. Shanxi Kangbao Biological Product Main Business
Table 152. Shanxi Kangbao Biological Product Latest Developments
LIST OFFIGURES
Figure 1. Picture of Passive Immunizing Drugs against Rabies
Figure 2. Passive Immunizing Drugs against Rabies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Immunizing Drugs against Rabies Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Passive Immunizing Drugs against Rabies Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Passive Immunizing Drugs against Rabies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Passive Immunizing Drugs against Rabies Sales Market Share by Country/Region (2023)
Figure 10. Passive Immunizing Drugs against Rabies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Rabies Immunoglobulin
Figure 12. Product Picture of Anti-rabies Serum
Figure 13. Product Picture of Rabies Virus Monoclonal Antibody
Figure 14. Global Passive Immunizing Drugs against Rabies Sales Market Share byType in 2023
Figure 15. Global Passive Immunizing Drugs against Rabies Revenue Market Share byType (2019-2024)
Figure 16. Passive Immunizing Drugs against Rabies Consumed in Category II Exposure
Figure 17. Global Passive Immunizing Drugs against Rabies Market: Category II Exposure (2019-2024) & (K Dose)
Figure 18. Passive Immunizing Drugs against Rabies Consumed in Category III Exposure
Figure 19. Global Passive Immunizing Drugs against Rabies Market: Category III Exposure (2019-2024) & (K Dose)
Figure 20. Global Passive Immunizing Drugs against Rabies Sale Market Share by Application (2023)
Figure 21. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application in 2023
Figure 22. Passive Immunizing Drugs against Rabies Sales by Company in 2023 (K Dose)
Figure 23. Global Passive Immunizing Drugs against Rabies Sales Market Share by Company in 2023
Figure 24. Passive Immunizing Drugs against Rabies Revenue by Company in 2023 ($ millions)
Figure 25. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Company in 2023
Figure 26. Global Passive Immunizing Drugs against Rabies Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 29. Americas Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 30. APAC Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 31. APAC Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 32. Europe Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 33. Europe Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 34. Middle East & Africa Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 35. Middle East & Africa Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 36. Americas Passive Immunizing Drugs against Rabies Sales Market Share by Country in 2023
Figure 37. Americas Passive Immunizing Drugs against Rabies Revenue Market Share by Country (2019-2024)
Figure 38. Americas Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 39. Americas Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 40. United States Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 41. Canada Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 42. Mexico Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 43. Brazil Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 44. APAC Passive Immunizing Drugs against Rabies Sales Market Share by Region in 2023
Figure 45. APAC Passive Immunizing Drugs against Rabies Revenue Market Share by Region (2019-2024)
Figure 46. APAC Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 47. APAC Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 48. China Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 49. Japan Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 50. South Korea Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 51. Southeast Asia Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 52. India Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 53. Australia Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 54. ChinaTaiwan Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 55. Europe Passive Immunizing Drugs against Rabies Sales Market Share by Country in 2023
Figure 56. Europe Passive Immunizing Drugs against Rabies Revenue Market Share by Country (2019-2024)
Figure 57. Europe Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 58. Europe Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 59. Germany Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 60.France Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 61. UK Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 62. Italy Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 63. Russia Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 64. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Market Share by Country (2019-2024)
Figure 65. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 66. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 67. Egypt Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 68. South Africa Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 69. Israel Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 70.Turkey Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 71. GCC Countries Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Passive Immunizing Drugs against Rabies in 2023
Figure 73. Manufacturing Process Analysis of Passive Immunizing Drugs against Rabies
Figure 74. Industry Chain Structure of Passive Immunizing Drugs against Rabies
Figure 75. Channels of Distribution
Figure 76. Global Passive Immunizing Drugs against Rabies Sales MarketForecast by Region (2025-2030)
Figure 77. Global Passive Immunizing Drugs against Rabies Revenue Market ShareForecast by Region (2025-2030)
Figure 78. Global Passive Immunizing Drugs against Rabies Sales Market ShareForecast byType (2025-2030)
Figure 79. Global Passive Immunizing Drugs against Rabies Revenue Market ShareForecast byType (2025-2030)
Figure 80. Global Passive Immunizing Drugs against Rabies Sales Market ShareForecast by Application (2025-2030)
Figure 81. Global Passive Immunizing Drugs against Rabies Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Immunizing Drugs against Rabies Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Passive Immunizing Drugs against Rabies by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Passive Immunizing Drugs against Rabies by Country/Region, 2019, 2023 & 2030
2.2 Passive Immunizing Drugs against Rabies Segment by Type
2.2.1 Rabies Immunoglobulin
2.2.2 Anti-rabies Serum
2.2.3 Rabies Virus Monoclonal Antibody
2.3 Passive Immunizing Drugs against Rabies Sales by Type
2.3.1 Global Passive Immunizing Drugs against Rabies Sales Market Share by Type (2019-2024)
2.3.2 Global Passive Immunizing Drugs against Rabies Revenue and Market Share by Type (2019-2024)
2.3.3 Global Passive Immunizing Drugs against Rabies Sale Price by Type (2019-2024)
2.4 Passive Immunizing Drugs against Rabies Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Passive Immunizing Drugs against Rabies Sales by Application
2.5.1 Global Passive Immunizing Drugs against Rabies Sale Market Share by Application (2019-2024)
2.5.2 Global Passive Immunizing Drugs against Rabies Revenue and Market Share by Application (2019-2024)
2.5.3 Global Passive Immunizing Drugs against Rabies Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Passive Immunizing Drugs against Rabies Breakdown Data by Company
3.1.1 Global Passive Immunizing Drugs against Rabies Annual Sales by Company (2019-2024)
3.1.2 Global Passive Immunizing Drugs against Rabies Sales Market Share by Company (2019-2024)
3.2 Global Passive Immunizing Drugs against Rabies Annual Revenue by Company (2019-2024)
3.2.1 Global Passive Immunizing Drugs against Rabies Revenue by Company (2019-2024)
3.2.2 Global Passive Immunizing Drugs against Rabies Revenue Market Share by Company (2019-2024)
3.3 Global Passive Immunizing Drugs against Rabies Sale Price by Company
3.4 Key Manufacturers Passive Immunizing Drugs against Rabies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Immunizing Drugs against Rabies Product Location Distribution
3.4.2 Players Passive Immunizing Drugs against Rabies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PASSIVE IMMUNIZING DRUGS AGAINST RABIES BY GEOGRAPHIC REGION
4.1 World Historic Passive Immunizing Drugs against Rabies Market Size by Geographic Region (2019-2024)
4.1.1 Global Passive Immunizing Drugs against Rabies Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Passive Immunizing Drugs against Rabies Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Passive Immunizing Drugs against Rabies Market Size by Country/Region (2019-2024)
4.2.1 Global Passive Immunizing Drugs against Rabies Annual Sales by Country/Region (2019-2024)
4.2.2 Global Passive Immunizing Drugs against Rabies Annual Revenue by Country/Region (2019-2024)
4.3 Americas Passive Immunizing Drugs against Rabies Sales Growth
4.4 APAC Passive Immunizing Drugs against Rabies Sales Growth
4.5 Europe Passive Immunizing Drugs against Rabies Sales Growth
4.6 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Growth
5 AMERICAS
5.1 Americas Passive Immunizing Drugs against Rabies Sales by Country
5.1.1 Americas Passive Immunizing Drugs against Rabies Sales by Country (2019-2024)
5.1.2 Americas Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024)
5.2 Americas Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
5.3 Americas Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Immunizing Drugs against Rabies Sales by Region
6.1.1 APAC Passive Immunizing Drugs against Rabies Sales by Region (2019-2024)
6.1.2 APAC Passive Immunizing Drugs against Rabies Revenue by Region (2019-2024)
6.2 APAC Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
6.3 APAC Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Immunizing Drugs against Rabies by Country
7.1.1 Europe Passive Immunizing Drugs against Rabies Sales by Country (2019-2024)
7.1.2 Europe Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024)
7.2 Europe Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
7.3 Europe Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Immunizing Drugs against Rabies by Country
8.1.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Country (2019-2024)
8.1.2 Middle East & Africa Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024)
8.2 Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Type (2019-2024)
8.3 Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Immunizing Drugs against Rabies
10.3 Manufacturing Process Analysis of Passive Immunizing Drugs against Rabies
10.4 Industry Chain Structure of Passive Immunizing Drugs against Rabies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Immunizing Drugs against Rabies Distributors
11.3 Passive Immunizing Drugs against Rabies Customer
12 WORLD FORECAST REVIEW FOR PASSIVE IMMUNIZING DRUGS AGAINST RABIES BY GEOGRAPHIC REGION
12.1 Global Passive Immunizing Drugs against Rabies Market Size Forecast by Region
12.1.1 Global Passive Immunizing Drugs against Rabies Forecast by Region (2025-2030)
12.1.2 Global Passive Immunizing Drugs against Rabies Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Passive Immunizing Drugs against Rabies Forecast by Type (2025-2030)
12.7 Global Passive Immunizing Drugs against Rabies Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Kedrion Biopharma
13.1.1 Kedrion Biopharma Company Information
13.1.2 Kedrion Biopharma Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.1.3 Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Kedrion Biopharma Main Business Overview
13.1.5 Kedrion Biopharma Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.2.3 Grifols Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Kamada
13.4.1 Kamada Company Information
13.4.2 Kamada Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.4.3 Kamada Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Kamada Main Business Overview
13.4.5 Kamada Latest Developments
13.5 Zydus Lifesciences
13.5.1 Zydus Lifesciences Company Information
13.5.2 Zydus Lifesciences Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.5.3 Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Zydus Lifesciences Main Business Overview
13.5.5 Zydus Lifesciences Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.6.3 Serum Institute of India Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 Sichuan Yuanda Shuyang Pharmaceutical
13.7.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
13.7.2 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.7.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sichuan Yuanda Shuyang Pharmaceutical Main Business Overview
13.7.5 Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
13.8 Sinopharm Group
13.8.1 Sinopharm Group Company Information
13.8.2 Sinopharm Group Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.8.3 Sinopharm Group Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sinopharm Group Main Business Overview
13.8.5 Sinopharm Group Latest Developments
13.9 Haffkine Bio-Pharmaceutical
13.9.1 Haffkine Bio-Pharmaceutical Company Information
13.9.2 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.9.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Haffkine Bio-Pharmaceutical Main Business Overview
13.9.5 Haffkine Bio-Pharmaceutical Latest Developments
13.10 Bharat Biotech
13.10.1 Bharat Biotech Company Information
13.10.2 Bharat Biotech Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.10.3 Bharat Biotech Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bharat Biotech Main Business Overview
13.10.5 Bharat Biotech Latest Developments
13.11 Sharon Bio-Medicine
13.11.1 Sharon Bio-Medicine Company Information
13.11.2 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.11.3 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sharon Bio-Medicine Main Business Overview
13.11.5 Sharon Bio-Medicine Latest Developments
13.12 Wuhan Institute of Biological Products
13.12.1 Wuhan Institute of Biological Products Company Information
13.12.2 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.12.3 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Wuhan Institute of Biological Products Main Business Overview
13.12.5 Wuhan Institute of Biological Products Latest Developments
13.13 North China Pharmaceutical
13.13.1 North China Pharmaceutical Company Information
13.13.2 North China Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.13.3 North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 North China Pharmaceutical Main Business Overview
13.13.5 North China Pharmaceutical Latest Developments
13.14 Xingmeng Biopharmaceuticals (Suzhou)
13.14.1 Xingmeng Biopharmaceuticals (Suzhou) Company Information
13.14.2 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.14.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Xingmeng Biopharmaceuticals (Suzhou) Main Business Overview
13.14.5 Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
13.15 Hualan Biological Engineering
13.15.1 Hualan Biological Engineering Company Information
13.15.2 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.15.3 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Hualan Biological Engineering Main Business Overview
13.15.5 Hualan Biological Engineering Latest Developments
13.16 Shanxi Kangbao Biological Product
13.16.1 Shanxi Kangbao Biological Product Company Information
13.16.2 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
13.16.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shanxi Kangbao Biological Product Main Business Overview
13.16.5 Shanxi Kangbao Biological Product Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Passive Immunizing Drugs against Rabies Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Passive Immunizing Drugs against Rabies Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Rabies Immunoglobulin
Table 4. Major Players of Anti-rabies Serum
Table 5. Major Players of Rabies Virus Monoclonal Antibody
Table 6. Global Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 7. Global Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Table 8. Global Passive Immunizing Drugs against Rabies Revenue byType (2019-2024) & ($ million)
Table 9. Global Passive Immunizing Drugs against Rabies Revenue Market Share byType (2019-2024)
Table 10. Global Passive Immunizing Drugs against Rabies Sale Price byType (2019-2024) & (US$/Dose)
Table 11. Global Passive Immunizing Drugs against Rabies Sale by Application (2019-2024) & (K Dose)
Table 12. Global Passive Immunizing Drugs against Rabies Sale Market Share by Application (2019-2024)
Table 13. Global Passive Immunizing Drugs against Rabies Revenue by Application (2019-2024) & ($ million)
Table 14. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application (2019-2024)
Table 15. Global Passive Immunizing Drugs against Rabies Sale Price by Application (2019-2024) & (US$/Dose)
Table 16. Global Passive Immunizing Drugs against Rabies Sales by Company (2019-2024) & (K Dose)
Table 17. Global Passive Immunizing Drugs against Rabies Sales Market Share by Company (2019-2024)
Table 18. Global Passive Immunizing Drugs against Rabies Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Company (2019-2024)
Table 20. Global Passive Immunizing Drugs against Rabies Sale Price by Company (2019-2024) & (US$/Dose)
Table 21. Key Manufacturers Passive Immunizing Drugs against Rabies Producing Area Distribution and Sales Area
Table 22. Players Passive Immunizing Drugs against Rabies Products Offered
Table 23. Passive Immunizing Drugs against Rabies Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Passive Immunizing Drugs against Rabies Sales by Geographic Region (2019-2024) & (K Dose)
Table 27. Global Passive Immunizing Drugs against Rabies Sales Market Share Geographic Region (2019-2024)
Table 28. Global Passive Immunizing Drugs against Rabies Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Passive Immunizing Drugs against Rabies Sales by Country/Region (2019-2024) & (K Dose)
Table 31. Global Passive Immunizing Drugs against Rabies Sales Market Share by Country/Region (2019-2024)
Table 32. Global Passive Immunizing Drugs against Rabies Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Passive Immunizing Drugs against Rabies Sales by Country (2019-2024) & (K Dose)
Table 35. Americas Passive Immunizing Drugs against Rabies Sales Market Share by Country (2019-2024)
Table 36. Americas Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 38. Americas Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 39. APAC Passive Immunizing Drugs against Rabies Sales by Region (2019-2024) & (K Dose)
Table 40. APAC Passive Immunizing Drugs against Rabies Sales Market Share by Region (2019-2024)
Table 41. APAC Passive Immunizing Drugs against Rabies Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 43. APAC Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 44. Europe Passive Immunizing Drugs against Rabies Sales by Country (2019-2024) & (K Dose)
Table 45. Europe Passive Immunizing Drugs against Rabies Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 47. Europe Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 48. Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Country (2019-2024) & (K Dose)
Table 49. Middle East & Africa Passive Immunizing Drugs against Rabies Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Passive Immunizing Drugs against Rabies Sales byType (2019-2024) & (K Dose)
Table 51. Middle East & Africa Passive Immunizing Drugs against Rabies Sales by Application (2019-2024) & (K Dose)
Table 52. Key Market Drivers & Growth Opportunities of Passive Immunizing Drugs against Rabies
Table 53. Key Market Challenges & Risks of Passive Immunizing Drugs against Rabies
Table 54. Key IndustryTrends of Passive Immunizing Drugs against Rabies
Table 55. Passive Immunizing Drugs against Rabies Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Passive Immunizing Drugs against Rabies Distributors List
Table 58. Passive Immunizing Drugs against Rabies Customer List
Table 59. Global Passive Immunizing Drugs against Rabies SalesForecast by Region (2025-2030) & (K Dose)
Table 60. Global Passive Immunizing Drugs against Rabies RevenueForecast by Region (2025-2030) & ($ millions)
Table 61. Americas Passive Immunizing Drugs against Rabies SalesForecast by Country (2025-2030) & (K Dose)
Table 62. Americas Passive Immunizing Drugs against Rabies Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 63. APAC Passive Immunizing Drugs against Rabies SalesForecast by Region (2025-2030) & (K Dose)
Table 64. APAC Passive Immunizing Drugs against Rabies Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Europe Passive Immunizing Drugs against Rabies SalesForecast by Country (2025-2030) & (K Dose)
Table 66. Europe Passive Immunizing Drugs against Rabies RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Passive Immunizing Drugs against Rabies SalesForecast by Country (2025-2030) & (K Dose)
Table 68. Middle East & Africa Passive Immunizing Drugs against Rabies RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Global Passive Immunizing Drugs against Rabies SalesForecast byType (2025-2030) & (K Dose)
Table 70. Global Passive Immunizing Drugs against Rabies RevenueForecast byType (2025-2030) & ($ millions)
Table 71. Global Passive Immunizing Drugs against Rabies SalesForecast by Application (2025-2030) & (K Dose)
Table 72. Global Passive Immunizing Drugs against Rabies RevenueForecast by Application (2025-2030) & ($ millions)
Table 73. Kedrion Biopharma Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 74. Kedrion Biopharma Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 75. Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 76. Kedrion Biopharma Main Business
Table 77. Kedrion Biopharma Latest Developments
Table 78. Grifols Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 79. Grifols Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 80. Grifols Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 81. Grifols Main Business
Table 82. Grifols Latest Developments
Table 83. Sanofi Pasteur Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 85. Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Kamada Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 89. Kamada Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 90. Kamada Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 91. Kamada Main Business
Table 92. Kamada Latest Developments
Table 93. Zydus Lifesciences Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 94. Zydus Lifesciences Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 95. Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 96. Zydus Lifesciences Main Business
Table 97. Zydus Lifesciences Latest Developments
Table 98. Serum Institute of India Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 100. Serum Institute of India Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments
Table 103. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 104. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 105. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 106. Sichuan Yuanda Shuyang Pharmaceutical Main Business
Table 107. Sichuan Yuanda Shuyang Pharmaceutical Latest Developments
Table 108. Sinopharm Group Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 109. Sinopharm Group Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 110. Sinopharm Group Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 111. Sinopharm Group Main Business
Table 112. Sinopharm Group Latest Developments
Table 113. Haffkine Bio-Pharmaceutical Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 114. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 115. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 116. Haffkine Bio-Pharmaceutical Main Business
Table 117. Haffkine Bio-Pharmaceutical Latest Developments
Table 118. Bharat Biotech Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 119. Bharat Biotech Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 120. Bharat Biotech Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 121. Bharat Biotech Main Business
Table 122. Bharat Biotech Latest Developments
Table 123. Sharon Bio-Medicine Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 124. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 125. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 126. Sharon Bio-Medicine Main Business
Table 127. Sharon Bio-Medicine Latest Developments
Table 128. Wuhan Institute of Biological Products Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 130. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 131. Wuhan Institute of Biological Products Main Business
Table 132. Wuhan Institute of Biological Products Latest Developments
Table 133. North China Pharmaceutical Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 134. North China Pharmaceutical Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 135. North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 136. North China Pharmaceutical Main Business
Table 137. North China Pharmaceutical Latest Developments
Table 138. Xingmeng Biopharmaceuticals (Suzhou) Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 139. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 140. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 141. Xingmeng Biopharmaceuticals (Suzhou) Main Business
Table 142. Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
Table 143. Hualan Biological Engineering Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 144. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 145. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 146. Hualan Biological Engineering Main Business
Table 147. Hualan Biological Engineering Latest Developments
Table 148. Shanxi Kangbao Biological Product Basic Information, Passive Immunizing Drugs against Rabies Manufacturing Base, Sales Area and Its Competitors
Table 149. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product Portfolios and Specifications
Table 150. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 151. Shanxi Kangbao Biological Product Main Business
Table 152. Shanxi Kangbao Biological Product Latest Developments
LIST OFFIGURES
Figure 1. Picture of Passive Immunizing Drugs against Rabies
Figure 2. Passive Immunizing Drugs against Rabies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Immunizing Drugs against Rabies Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Passive Immunizing Drugs against Rabies Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Passive Immunizing Drugs against Rabies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Passive Immunizing Drugs against Rabies Sales Market Share by Country/Region (2023)
Figure 10. Passive Immunizing Drugs against Rabies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Rabies Immunoglobulin
Figure 12. Product Picture of Anti-rabies Serum
Figure 13. Product Picture of Rabies Virus Monoclonal Antibody
Figure 14. Global Passive Immunizing Drugs against Rabies Sales Market Share byType in 2023
Figure 15. Global Passive Immunizing Drugs against Rabies Revenue Market Share byType (2019-2024)
Figure 16. Passive Immunizing Drugs against Rabies Consumed in Category II Exposure
Figure 17. Global Passive Immunizing Drugs against Rabies Market: Category II Exposure (2019-2024) & (K Dose)
Figure 18. Passive Immunizing Drugs against Rabies Consumed in Category III Exposure
Figure 19. Global Passive Immunizing Drugs against Rabies Market: Category III Exposure (2019-2024) & (K Dose)
Figure 20. Global Passive Immunizing Drugs against Rabies Sale Market Share by Application (2023)
Figure 21. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application in 2023
Figure 22. Passive Immunizing Drugs against Rabies Sales by Company in 2023 (K Dose)
Figure 23. Global Passive Immunizing Drugs against Rabies Sales Market Share by Company in 2023
Figure 24. Passive Immunizing Drugs against Rabies Revenue by Company in 2023 ($ millions)
Figure 25. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Company in 2023
Figure 26. Global Passive Immunizing Drugs against Rabies Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 29. Americas Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 30. APAC Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 31. APAC Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 32. Europe Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 33. Europe Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 34. Middle East & Africa Passive Immunizing Drugs against Rabies Sales 2019-2024 (K Dose)
Figure 35. Middle East & Africa Passive Immunizing Drugs against Rabies Revenue 2019-2024 ($ millions)
Figure 36. Americas Passive Immunizing Drugs against Rabies Sales Market Share by Country in 2023
Figure 37. Americas Passive Immunizing Drugs against Rabies Revenue Market Share by Country (2019-2024)
Figure 38. Americas Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 39. Americas Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 40. United States Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 41. Canada Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 42. Mexico Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 43. Brazil Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 44. APAC Passive Immunizing Drugs against Rabies Sales Market Share by Region in 2023
Figure 45. APAC Passive Immunizing Drugs against Rabies Revenue Market Share by Region (2019-2024)
Figure 46. APAC Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 47. APAC Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 48. China Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 49. Japan Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 50. South Korea Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 51. Southeast Asia Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 52. India Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 53. Australia Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 54. ChinaTaiwan Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 55. Europe Passive Immunizing Drugs against Rabies Sales Market Share by Country in 2023
Figure 56. Europe Passive Immunizing Drugs against Rabies Revenue Market Share by Country (2019-2024)
Figure 57. Europe Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 58. Europe Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 59. Germany Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 60.France Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 61. UK Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 62. Italy Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 63. Russia Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 64. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Market Share by Country (2019-2024)
Figure 65. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Market Share byType (2019-2024)
Figure 66. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Market Share by Application (2019-2024)
Figure 67. Egypt Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 68. South Africa Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 69. Israel Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 70.Turkey Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 71. GCC Countries Passive Immunizing Drugs against Rabies Revenue Growth 2019-2024 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Passive Immunizing Drugs against Rabies in 2023
Figure 73. Manufacturing Process Analysis of Passive Immunizing Drugs against Rabies
Figure 74. Industry Chain Structure of Passive Immunizing Drugs against Rabies
Figure 75. Channels of Distribution
Figure 76. Global Passive Immunizing Drugs against Rabies Sales MarketForecast by Region (2025-2030)
Figure 77. Global Passive Immunizing Drugs against Rabies Revenue Market ShareForecast by Region (2025-2030)
Figure 78. Global Passive Immunizing Drugs against Rabies Sales Market ShareForecast byType (2025-2030)
Figure 79. Global Passive Immunizing Drugs against Rabies Revenue Market ShareForecast byType (2025-2030)
Figure 80. Global Passive Immunizing Drugs against Rabies Sales Market ShareForecast by Application (2025-2030)
Figure 81. Global Passive Immunizing Drugs against Rabies Revenue Market ShareForecast by Application (2025-2030)
